Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial
Clicks: 266
ID: 120502
2003
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
71.6
/100
259 views
213 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Abstract. The efficacy and safety of high-dose intravenous polyspecific immunoglobulin G (IVIG) as adjunctive therapy in streptococcal toxic shock syndrome (ST
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (21 words).
Try re-searching for a better abstract.
| Reference Key |
jessica2003clinicalintravenous
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Darenberg, Jessica;Ihendyane, Nahla;Sjölin, Jan;Aufwerber, Ewa;Haidl, Sven;Follin, Per;Andersson, Jan;Norrby-Teglund, Anna;The Streptlg Study Group; |
| Journal | clinical infectious diseases |
| Year | 2003 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.